Last reviewed · How we verify

NCT05580471

A Randomized Control Study of Anti-Adhesion Agent After Colorectal Surgery

Status unknown NA Last updated 14 October 2022
What this trial tests

NA trial testing Use 4DryField in Adhesion in 40 participants. Status unknown.

Timeline
5 March 2022
Primary endpoint
4 September 2024
4 September 2024

Quick facts

Lead sponsorTaipei Medical University Shuang Ho Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment40
Start date5 March 2022
Primary completion4 September 2024
Estimated completion4 September 2024
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Taipei Medical University Shuang Ho Hospital

Who can join

Adults 20 to 100, any sex, with Adhesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project is to evaluate the difference of post-operation adhesion severity and adhesion area of patient received 4DryField after colorectal surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Adhesion

Currently open trials in the same condition.

Other Taipei Medical University Shuang Ho Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05580471.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing